Clinical Trial Update: Dapagliflozin Treatment in Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating dapagliflozin in adults with type 2 diabetes, including those with impaired renal function, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Emerald Clinical Inc. | Conditions: Diabetes Mellitus, Type 2, Impaired Renal Function | Phase 4 | Status: COMPLETED